Marked differences in the IGF system that are associated with migration in comparable populations of Gujaratis living in Sandwell, UK, and Gujarat, India

Diabetologia

Volumn 48, Issue 9, 2005, Pages 1756-1765

  Heald, A H ^a   Anderson, S G ^b,c   Vyas, A ^b,c   Siddals, K ^a   Patel, J ^b,d   Yates, A P ^c   Bhatnagar, D ^c   Prabhakaran, D ^e   Hughes, E ^d   Rudenski, A ^a   Durrington, P ^c   Gibson, J M ^a   Cruickshank, J K ^b,c  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d SANDWELL GENERAL HOSPITAL   (United Kingdom)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

IGF; IGFBP 1; IGFBP 3; Insulin resistance; Lifestyle; Migration

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; ANTHROPOMETRY; ARTICLE; BODY MASS; CALORIC INTAKE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMMUNITY; COMPARATIVE STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; FEMALE; GLUCOSE TOLERANCE; HUMAN; INDIA; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIFESTYLE; MALE; METABOLISM; MIGRATION; POPULATION; PRIORITY JOURNAL; UNITED KINGDOM;

BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; BODY SIZE; EMIGRATION AND IMMIGRATION; ENERGY INTAKE; FASTING; FEMALE; GREAT BRITAIN; HUMANS; INDIA; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; ISLETS OF LANGERHANS; MALE; MIDDLE AGED;

EID: 24944476581     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-1871-7     Document Type: Article

References (41)

1. Mbanya JC, Cruickshank JK, Forrester T et al (1999) Standardised comparison of glucose tolerance in west African origin populations: rural/urban Cameroon, Jamaica & Caribbean migrants to Britain. Diabetes Care 22:434-440
2. Balajaran R (1995) Ethnicity and variations in the nation's health. Health Trends 27:114-119
3. Shaukat N, de Bono DP, Cruickshank JK (1993) Clinical features, risk factors and referral delay in British patients of Indian and European origin with angina matched for age and extent of coronary atheroma. BMJ 307:717-718
4. Cruickshank JK, Cooper J, Burnett M et al (1991) Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 338:842-847
5. McKeigue PM, Shah B, Marmot MG (1991) Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians. Lancet 337:382-386
6. Sandhu MS, Heald AH, Gibson JM et al (2002) Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 359:1740-1745
7. Fath KA, Alexander RW, Delafontaine P (1993) Abdominal coarctation increases insulin-like growth factor I mRNA levels in rat aorta. Circ Res 72:271-277
8. Ververis JJ, Ku L, Delafontaine P (1993) Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circ Res 72:1285-1292
9. Delafontaine P (1995) Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Res 30:825-834
10. Duerr RL, Huang S, Miraliakbar HR et al (1995) Insulin-like growth factor-I enhances ventricular hypertrophy and function during the onset of experimental heart failure. J Clin Invest 95:619-627
11. Juul A, Scheike T, Davidsen M, Gyllenborg J, Jorgensen T (2002) Low serum insulin-like growth factor I is associated with increased risk of ischaemic heart disease: a population-based case-control study. Circulation 106:939-944
12. Li Q, Li B, Wang X et al (1997) Overexpression of insulin-like growth factor-I in mice protects from myocyte death after infarction, attenuating ventricular wall dilatation, wall stress and cardiac hypertrophy. J Clin Invest 100:1991-1999
13. Vasan RS, Sullivan LM, D'Agostino RB et al (2003) Serum insulin-like growth factor I and risk for heart failure in elderly individuals without a previous myocardial infarction: the Framingham Heart Study. Ann Intern Med 139:642-648
14. Lee PD, Giudice LC, Conover CA et al (1997) Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 216:319-357
15. Heald AH, Cruickshank JK, Riste LK et al (2001) Close relationship of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in 2 populations. Diabetologia 44:333-339
16. Cruickshank JK, Heald AH, Andersen S et al (2001) Epidemiology of the insulin-like growth factor system in three ethnic groups. Am J Epidemiol 154:504-513
17. Heald AH, Siddals KW, Fraser W et al (2002) Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes. Diabetes 51:2629-2636
18. Vaessen N, Heutink P, Janssen JA et al (2001) A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50:637-642
19. Hankinson SE, Willett WC, Colditz GA et al (1998) Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 351:1393-1396
20. Chan JM, Stampfer MJ, Giovannucci E et al (1998) Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 279:563-566
21. Chaturvedi N, McKeigue PM (1994) Methods for epidemiological surveys of ethnic minority groups. J Epidemiol Community Health 48:107-111
22. Alberti KGMM, Zimmet PZ, for the WHO Consultation (1998) Definition, diagnosis and classification of diabetes mellitus and its complications: Part I. Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539-553
23. Westwood M, Gibson JM, Davies AJ et al (1994) The phosphorylation pattern of insulin-like growth factor binding protein-1 in normal plasma is different from that in amniotic fluid and changes during pregnancy. J Clin Endocrinol Metab 79:1735-1741
24. Gordon C, Yates AP, Davies D (1985) Evidence for a direct action of exogenous insulin on the pancreatic islets of diabetic mice: islet response to insulin pre-incubation. Diabetologia 28:291-294
25. Matthews DR, Hosker JB, Rudenski AS et al (1985) Homeostasis model assessment: insulin resistance and beta cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419
26. Ferrannini E, Mari A (1998) How to measure insulin sensitivity. J Hypertens 16:895-906
27. Silverman BW (1986) Density estimation for statistics and data analysis, monographs on statistics and applied probability. Chapman and Hall, London
28. Villafuerte BC, Zhang WN, Phillips LW (1996) Insulin and insulin-like growth factor-I regulate hepatic insulin-like growth factor binding protein-3 by different mechanisms. Mol Endocrinol 10:622-630
29. Underwood LE, Clemmons DR, Maes M et al (1986) Regulation of somatomedin-C/insulin-like growth factor I by nutrients. Horm Res 24:166-176
30. Kraegen EW, Clark PW, Jenkins AB et al (1991) Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40:1397-1403
31. Boden G (1997) Role of fatty acids in the pathogenesis of insulin resistance and NIDDM. Diabetes 46:3-10
32. Conover CA, Lee PDK, Kanaley JA et al (1992) Insulin regulation of insulin-like growth factor binding protein-1 in obese and non-obese humans. J Clin Endocrinol Metab 74:1355-1360
33. Charles MA, Eschewege E, Thibult N et al (1997) The role of non-esterified fatty acids in deterioration of glucose tolerance in Caucasian subjects: the Paris Prospective Study. Diabetologia 40:1101-1106
34. Stein DT, Stevenson BE, Chester MW et al (1997) The insulinotropic potency of fatty acids is influenced profoundly by their chain length and degree of saturation. J Clin Invest 100:398-403
35. Paolisso G, Gambardella A, Amato R et al (1995) Opposite effects of short- and long-term fatty acid infusion on insulin secretion in healthy subjects. Diabetologia 398:1295-1299
36. Maron DJ, Fair JM, Haskell WL (1991) Saturated fat intake and insulin resistance in men with coronary artery disease. The Stanford coronary risk intervention project. Circulation 84:2020-2027
37. Mohamed-Ali V, Pinkney JH, Panahloo A et al (1999) Insulin-like growth factor binding protein in NIDDM. Clin Endocrinol 50:221-228
38. Bavenholm PN, Pigon J, Ostenson CG et al (2001) Insulin sensitivity of suppression of endogenous glucose production is the single most important determinant of glucose tolerance. Diabetes 50:1449-1454
39. Firth RG, Bell PM, Marsh HM et al (1986) Postprandial hyperglycaemia in patients with NIDDM: role of hepatic and extrahepatic tissues. J Clin Invest 77:1525-1532
40. Jones JI, Clemmons DR (1995) Insulin-like growth factors and their binding proteins: biological functions. Endocr Rev 16:3-34
41. Lee PD, Giudice LC, Conover CA et al (1997) Insulin-like growth factor binding protein-1: recent findings and new directions. Proc Soc Exp Biol Med 216:319-357